SEC Form 4 · accession 0001209191-15-032533
Receptos, Inc. · RCPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Waage Christian
Officer — Senior VP & General Counsel
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 9:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001463729
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 1, 2015 | A | 9,500 | $0.00 | A | 9,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents time-based restricted stock units which vest in four equal annual installments on the anniversary of the date of grant. An additional 9,500 performance-based restricted stock units will vest, if at all, upon the first filing of a New Drug Application (or foreign equivalent) by Receptos, Inc. (the "Company") for any of the Company's product candidates in any geography within 10 years of the date of grant.